Enzyme Nutrition Men's Multivitamin
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera Source : Fruit Extraction ratio : 1,000:1 Dry plant equivalent : 5,000 milligramme Potency : 5 % Resveratrol | 5 milligramme | Not calculated |
| Riboflavine Source : Riboflavine | 1.75 milligramme | 7,000 µg |
| Cuivre Source : Sulfate de cuivre (II) | 25 microgrammes | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 7.5 milligramme | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 22.5 FCC BGU | Not calculated |
| Sélénium Source : Levure enrichie de sélénium | 12.5 microgrammes | Not calculated |
| Vitamine K2 Source : Ménaquinone 4 | 6.25 microgrammes | Not calculated |
| Brassica oleracea var. italica Source : Sommité | 5 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.5 milligramme | 10,000 µg |
| Lactobacillus acidophilus Source : Cellule entière | 1.79 milligramme | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 250 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : DDS-1 | 1.79 milligramme | Not calculated |
| Lactobacillus acidophilus Source : DDS-1 | 250 Millions d'UFC | Not calculated |
| Manganèse Source : Chlorure de manganèse (II) | 0.5 milligramme | 2,000 µg |
| Iode Source : Iodure de potassium | 31.25 microgrammes | Not calculated |
| Diastase du malt Source : Diastase du malt | 0.625 milligramme | Not calculated |
| Diastase du malt Source : Diastase du malt | 25 FCC DU | Not calculated |
| Bêta-carotène tout trans Source : Daucus carota subsp. sativus - racine Potency : 1,200 UI | 750 microgrammes | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 1.75 milligramme | 7,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 150 UI | 3.75 microgrammes | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 2,500 FCC HUT | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 2,500 FCC HUT | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 3.125 milligramme | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 3.125 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine | 3.25 milligramme | Not calculated |
| Vitamine K1 Source : Medicago sativa - plante entière | 6.25 microgrammes | Not calculated |
| Vitamine C Source : Citrus aurantium - fruit | 15 milligramme | 60,000 µg |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 14.84 milligramme | Not calculated |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 47.5 FCC PU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 750 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Bacillus subtilis - cellule entière | 750 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 6.25 milligramme | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Bacillus subtilis - cellule entière | 6.25 milligramme | Not calculated |
| Lycium barbarum Source : Fruit Extraction ratio : 12:1 Dry plant equivalent : 60 milligramme | 5 milligramme | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 100 FCC PC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 0.1 milligramme | Not calculated |
| Potassium Source : Iodure de potassium | 250 microgrammes | Not calculated |
| Calcium Source : Chlorure de calcium | 3.75 milligramme | 15,000 µg |
| L-Glutathione Source : Glutathione | 250 microgrammes | Not calculated |
| Zinc Source : Chlorure de zinc | 3.75 milligramme | 15,000 µg |
| Chrome Source : Levure enrichie de chrome(III) | 12.5 microgrammes | Not calculated |
| Niacinamide | 5 milligramme | Not calculated |
| Magnésium Source : Chlorure de magnésium | 6.25 milligramme | 25,000 µg |
| Bore Source : Sodium borate | 250 microgrammes | Not calculated |
| Molybdène Source : Molybdate de sodium (VI) | 2.5 microgrammes | Not calculated |
| Mélange de concentré de tocophérol Source : Concentré de tocophérols, mélange Potency : 25 UI | 100 milligramme | Not calculated |
| Serratiopeptidase Source : Serratia - Cellule entière | 1.14 milligramme | Not calculated |
| Serratiopeptidase Source : Serratia - Cellule entière | 2,500 SPU | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 1.08 milligramme | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1.08 milligramme | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1.08 milligramme | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 123 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 123 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 123 FCC LU | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 0.34 milligramme | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 68 FCC SU | Not calculated |
| 1,4-bêta-D-mannane mannanohydrolase Source : Aspergillus niger - En entier | 200 FCC HCU | Not calculated |
| 1,4-bêta-D-mannane mannanohydrolase Source : Aspergillus niger - En entier | 0.25 milligramme | Not calculated |
| Adénosine-5'-acide triphosphorique Source : Adénosine triphosphate disodium | 0.25 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 0.25 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 0.25 milligramme | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 25 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 25 FCC CU | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 18.75 microgrammes | Not calculated |
| Folate Source : Medicago sativa - germe | 100 microgrammes | Not calculated |
| Biotine | 75 microgrammes | Not calculated |
| Choline Source : Chlorure de choline | 2.5 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Extrait de Levure, Eau, Ammonium sulphate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Digestive enzymes. Protease is a digestive aid; Protease helps digest proteins. Multi-vitamin/Multi-mineral supplement. Grape extract, Broccoli and Lycium provide antioxidants that help protect cells against the oxidative damage caused by free radicals; Selenium is an antioxidant for the maintenance of good health. Source of probiotics; Helps support intestinal/gastrointestinal health; Could promote a favorable gut flora. Helps to maintain the body's ability to metabolize nutrients. Vitamin K2 and Manganese help in the maintenance of bones. Vitamin D and Magnesium help in the development and maintenance of bones and teeth. Magnesium helps to maintain proper muscle function. Zinc helps to maintain healthy skin and immune function. Iodine helps in the function of the thyroid gland.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have diabetes, an auto-immune disorder, gastrointestinal lesions/ulcers, fever, vomiting, bloody diarrhoea, severe abdominal pain, or an estrogen-dependent cancer, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking anticoagulant/blood thinning agents or anti-inflammatory agents, or if you are having surgery. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in such a case, discontinue use.
- Contre-indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment),.
Product record
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80071570
- Status
- Active licence
- Licence date
- 2 August 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80071570
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitamine D
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Sources cited by Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- Serratiopeptidase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
Sources cited by Health Canada (1)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Enzyme Nutrition Men's Multivitamin”, https://compoatlas.com/en/supplements/canada/80071570-enzyme-nutrition-men-s-multivitamin, updated 2 August 2016.